Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinal

Detalhes bibliográficos
Ano de defesa: 2020
Autor(a) principal: Tamara Cristina Moreira Lopes
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Minas Gerais
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
DSS
Link de acesso: https://hdl.handle.net/1843/35206
Resumo: Inflammatory bowel disease is a group of digestive system diseases of complex pathogenesis, multifactorial and symptomatic treatment, and there is still no effective curative treatment. The imbalance of the local immune response seems to be the main trigger of the disease. In this context, macrophages play a fundamental role in pathology, and paradoxically, in the maintenance of intestinal homeostasis. Therefore, in this work, we evaluated the role of macrophages through their functional reprogramming for different activation profiles and used the regulatory profile in a therapy proposal to control the disease. The colitis model was reproduced by the administration of dextran sodium sulfate (DSS 3%) to the mice for 7 days. The animals submitted to colitis induction showed important clinical changes, measured through the Disease Activity Index (DAI), in addition to macroscopic and microscopic lesions. In assessing the role of macrophages in the pathogenesis of the disease, animals with colitis received treatment with two doses of macrophages reprogrammed in vitro, intraperitoneally. The results showed that groups treated with classically activated macrophages had even more severe disease. Histologically, it is possible to observe extensive areas of edema with intense transmural inflammatory infiltrate, presence of abscesses and fusion of the crypts, resulting in loss of colon architecture. On the other hand, animals treated with regulatory macrophages showed a significant improvement in all parameters analyzed, resulting in a lower DAI. It was observed macroscopically the colon with normal aspect and microscopically preserved areas of colon architecture, with few areas of lesion of the mucosa and submucosa. Fluorescence images showed the migration of macrophages to the inflamed colon after intraperitoneal injection of these cells. Thus, our results demonstrate that the polarization of macrophages to a regulatory profile was decisive in controlling experimental colitis in mice and that macrophages are a potential therapeutic target to be explored in the control of inflammatory bowel diseases.
id UFMG_4e013f89df341ef9d3bf65e2f68d23af
oai_identifier_str oai:repositorio.ufmg.br:1843/35206
network_acronym_str UFMG
network_name_str Repositório Institucional da UFMG
repository_id_str
spelling Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinalRegulatory macrophages control inflammation and promote recovery of experimental model of inflammatory bowel diseasePatologiaDoenças Inflamatórias IntestinaisColite UlcerativaSulfato de DextranaMacrófagosDoenças Inflamatórias intestinaisColite ulcerativaDSSMacrófagosInflammatory bowel disease is a group of digestive system diseases of complex pathogenesis, multifactorial and symptomatic treatment, and there is still no effective curative treatment. The imbalance of the local immune response seems to be the main trigger of the disease. In this context, macrophages play a fundamental role in pathology, and paradoxically, in the maintenance of intestinal homeostasis. Therefore, in this work, we evaluated the role of macrophages through their functional reprogramming for different activation profiles and used the regulatory profile in a therapy proposal to control the disease. The colitis model was reproduced by the administration of dextran sodium sulfate (DSS 3%) to the mice for 7 days. The animals submitted to colitis induction showed important clinical changes, measured through the Disease Activity Index (DAI), in addition to macroscopic and microscopic lesions. In assessing the role of macrophages in the pathogenesis of the disease, animals with colitis received treatment with two doses of macrophages reprogrammed in vitro, intraperitoneally. The results showed that groups treated with classically activated macrophages had even more severe disease. Histologically, it is possible to observe extensive areas of edema with intense transmural inflammatory infiltrate, presence of abscesses and fusion of the crypts, resulting in loss of colon architecture. On the other hand, animals treated with regulatory macrophages showed a significant improvement in all parameters analyzed, resulting in a lower DAI. It was observed macroscopically the colon with normal aspect and microscopically preserved areas of colon architecture, with few areas of lesion of the mucosa and submucosa. Fluorescence images showed the migration of macrophages to the inflamed colon after intraperitoneal injection of these cells. Thus, our results demonstrate that the polarization of macrophages to a regulatory profile was decisive in controlling experimental colitis in mice and that macrophages are a potential therapeutic target to be explored in the control of inflammatory bowel diseases.CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorUniversidade Federal de Minas Gerais2021-03-17T19:50:51Z2025-09-08T22:54:48Z2021-03-17T19:50:51Z2020-04-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfhttps://hdl.handle.net/1843/35206porTamara Cristina Moreira Lopesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMG2025-09-08T22:54:48Zoai:repositorio.ufmg.br:1843/35206Repositório InstitucionalPUBhttps://repositorio.ufmg.br/oairepositorio@ufmg.bropendoar:2025-09-08T22:54:48Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false
dc.title.none.fl_str_mv Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinal
Regulatory macrophages control inflammation and promote recovery of experimental model of inflammatory bowel disease
title Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinal
spellingShingle Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinal
Tamara Cristina Moreira Lopes
Patologia
Doenças Inflamatórias Intestinais
Colite Ulcerativa
Sulfato de Dextrana
Macrófagos
Doenças Inflamatórias intestinais
Colite ulcerativa
DSS
Macrófagos
title_short Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinal
title_full Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinal
title_fullStr Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinal
title_full_unstemmed Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinal
title_sort Macrófagos regulatórios controlam a inflamação e promovem a recuperação em modelo experimental de doença inflamatória intestinal
author Tamara Cristina Moreira Lopes
author_facet Tamara Cristina Moreira Lopes
author_role author
dc.contributor.author.fl_str_mv Tamara Cristina Moreira Lopes
dc.subject.por.fl_str_mv Patologia
Doenças Inflamatórias Intestinais
Colite Ulcerativa
Sulfato de Dextrana
Macrófagos
Doenças Inflamatórias intestinais
Colite ulcerativa
DSS
Macrófagos
topic Patologia
Doenças Inflamatórias Intestinais
Colite Ulcerativa
Sulfato de Dextrana
Macrófagos
Doenças Inflamatórias intestinais
Colite ulcerativa
DSS
Macrófagos
description Inflammatory bowel disease is a group of digestive system diseases of complex pathogenesis, multifactorial and symptomatic treatment, and there is still no effective curative treatment. The imbalance of the local immune response seems to be the main trigger of the disease. In this context, macrophages play a fundamental role in pathology, and paradoxically, in the maintenance of intestinal homeostasis. Therefore, in this work, we evaluated the role of macrophages through their functional reprogramming for different activation profiles and used the regulatory profile in a therapy proposal to control the disease. The colitis model was reproduced by the administration of dextran sodium sulfate (DSS 3%) to the mice for 7 days. The animals submitted to colitis induction showed important clinical changes, measured through the Disease Activity Index (DAI), in addition to macroscopic and microscopic lesions. In assessing the role of macrophages in the pathogenesis of the disease, animals with colitis received treatment with two doses of macrophages reprogrammed in vitro, intraperitoneally. The results showed that groups treated with classically activated macrophages had even more severe disease. Histologically, it is possible to observe extensive areas of edema with intense transmural inflammatory infiltrate, presence of abscesses and fusion of the crypts, resulting in loss of colon architecture. On the other hand, animals treated with regulatory macrophages showed a significant improvement in all parameters analyzed, resulting in a lower DAI. It was observed macroscopically the colon with normal aspect and microscopically preserved areas of colon architecture, with few areas of lesion of the mucosa and submucosa. Fluorescence images showed the migration of macrophages to the inflamed colon after intraperitoneal injection of these cells. Thus, our results demonstrate that the polarization of macrophages to a regulatory profile was decisive in controlling experimental colitis in mice and that macrophages are a potential therapeutic target to be explored in the control of inflammatory bowel diseases.
publishDate 2020
dc.date.none.fl_str_mv 2020-04-30
2021-03-17T19:50:51Z
2021-03-17T19:50:51Z
2025-09-08T22:54:48Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/1843/35206
url https://hdl.handle.net/1843/35206
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Minas Gerais
publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMG
instname:Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
instname_str Universidade Federal de Minas Gerais (UFMG)
instacron_str UFMG
institution UFMG
reponame_str Repositório Institucional da UFMG
collection Repositório Institucional da UFMG
repository.name.fl_str_mv Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)
repository.mail.fl_str_mv repositorio@ufmg.br
_version_ 1856413996592136192